share_log

Rosenblatt Maintains Buy on Imax, Raises Price Target to $30

Benzinga ·  Aug 25, 2023 07:33

Rosenblatt analyst Steve Frankel maintains Imax (NYSE:IMAX) with a Buy and raises the price target from $27 to $30.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment